State Street’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-127,015
| Closed | -$34K | – | 4949 |
|
|
2022
Q3 | $34K | Hold |
127,015
| – | – | ﹤0.01% | 4742 |
|
|
2022
Q2 | $98K | Hold |
127,015
| – | – | ﹤0.01% | 4549 |
|
|
2022
Q1 | $136K | Sell |
127,015
-25,805
| -17% | -$46.9K | ﹤0.01% | 4533 |
|
|
2021
Q4 | $290K | Hold |
152,820
| – | – | ﹤0.01% | 4195 |
|
|
2021
Q3 | $460K | Hold |
152,820
| – | – | ﹤0.01% | 4010 |
|
|
2021
Q2 | $598K | Sell |
152,820
-593,876
| -80% | -$2.46M | ﹤0.01% | 3797 |
|
|
2021
Q1 | $3.79M | Buy |
746,696
+357,566
| +92% | +$1.86M | ﹤0.01% | 3170 |
|
|
2020
Q4 | $1.59M | Sell |
389,130
-2,098
| -0.5% | -$10.3K | ﹤0.01% | 3449 |
|
|
2020
Q3 | $1.9M | Buy |
391,228
+68,418
| +21% | +$374K | ﹤0.01% | 3218 |
|
|
2020
Q2 | $1.79M | Buy |
+322,810
| New | +$1.48M | ﹤0.01% | 3224 |
|
|
2017
Q2 | – | Sell |
-274,811
| Closed | -$1.89M | – | 3754 |
|
|
2017
Q1 | $1.89M | Sell |
274,811
-26,172
| -9% | -$204K | ﹤0.01% | 3098 |
|
|
2016
Q4 | $2.81M | Buy |
300,983
+5,452
| +2% | +$49.1K | ﹤0.01% | 2969 |
|
|
2016
Q3 | $2.89M | Buy |
295,531
+27,375
| +10% | +$369K | ﹤0.01% | 2833 |
|
|
2016
Q2 | $3.79M | Buy |
268,156
+92,186
| +52% | +$1.44M | ﹤0.01% | 2761 |
|
|
2016
Q1 | $2.46M | Buy |
175,970
+61,985
| +54% | +$909K | ﹤0.01% | 2917 |
|
|
2015
Q4 | $2.33M | Buy |
113,985
+39,509
| +53% | +$609K | ﹤0.01% | 2940 |
|
|
2015
Q3 | $978K | Buy |
74,476
+4,760
| +7% | +$79K | ﹤0.01% | 3214 |
|
|
2015
Q2 | $1.07M | Sell |
69,716
-1,090
| -2% | -$20.9K | ﹤0.01% | 3223 |
|
|
2015
Q1 | $1.42M | Buy |
70,806
+8,827
| +14% | +$197K | ﹤0.01% | 3143 |
|
|
2014
Q4 | $1.3M | Buy |
61,979
+3,679
| +6% | +$74.9K | ﹤0.01% | 3198 |
|
|
2014
Q3 | $1.09M | Buy |
58,300
+20,166
| +53% | +$365K | ﹤0.01% | 3234 |
|
|
2014
Q2 | $880K | Buy |
+38,134
| New | +$672K | ﹤0.01% | 3267 |
|
State Street's AGTC Position: Q4 2022 in Review
State Street sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 127,015 shares — an estimated $34K sold.
State Street first reported a position in AGTC in Q2 2014 and held it in 22 quarters. The position peaked at $3.79M in Q2 2016. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- State Street reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- State Street sold 127,015 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $34K.
- State Street first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 22 quarters.
- State Street's Applied Genetic Technologies Corporation position peaked at $3.79M in Q2 2016.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on State Street's 13F filing for Q4 2022, filed 14 Feb 2023.